CSE/ROVA (CSE/ROVA)

Canadian Securities Exchange: CSE/ROVA · CAD

CA$0.06

+0.00 (0.0%)· Recorded snapshot

Market cap	12.1M
Revenue (ttm)	125.9K
Net income (ttm)	-5.5M
EPS (ttm)	-CA$0.03
Shares out	201.3M
Volume	1,000
Beta	-2.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 125.9K
Net income (ttm): -5.5M
EPS (ttm): -CA$0.03
Market cap: 12.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-165.9

P25 n/aP50 n/aP75 n/a

ROIC-44

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/ROVA indicators

Market & fundamental data

Available fields

148

Groups with data

Currency

CAD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Enterprise value	CAD 11.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	2022
Industry	Manufacturing Industries, not elsewhere classified
Is primary listing	Yes
ISIN number	CA0220931087
Last refreshed	2026-10-29
Last stock split date	2023-10-03
Last stock split type	Reverse
Market cap	CAD 12.1M
Price	CAD 0.06
Price currency	CAD
SIC code	3999
Stock price date	2026-10-28
Symbol	cse/ROVA
Website	https://www.altrovahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-48.47%
EV/Sales	94.66x
FCF / EV yield	-5.61%
FCF yield	-5.53%
P/B ratio	8.54x
P/S ratio	95.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	27.76%
Operating margin	-1,862.7%
Pretax margin	-4,393.09%
ROA	-31.44%
ROCE	-165.75%
ROE	-165.92%
ROIC	-43.97%
SBC / revenue	655.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	260.28%
Revenue growth	709.59%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 41,108
EBIT	CAD -2.3M
EBITDA	CAD -2.3M
EPS	CAD -0.03
FCF per share	CAD -0.00
Financing cash flow	CAD -4.4M
Free cash flow	CAD -668,210
Free cash flow minus SBC	CAD -1.5M
Gross profit	CAD 34,954
Investing cash flow	CAD 4.8M
Net cash flow	CAD -254,089
Net income	CAD -5.5M
Operating cash flow minus SBC	CAD -1.5M
Operating income	CAD -2.3M
Revenue	CAD 125,900
Stock-based compensation	CAD 825,725

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.63
Book value per share	CAD 0.01
Debt / equity	0
Goodwill	CAD 2.9M
Long-term assets	CAD 2.9M
Long-term liabilities	CAD 0
Net cash (debt)	CAD 162,703
Net cash / market cap	1.35%
Net cash growth	-63.42%
Net debt / equity	-0.12
Piotroski F-Score	2
Shareholders' equity	CAD 1.4M
Tangible book value	CAD -1.5M
Tangible book value per share	CAD -0.01
Total assets	CAD 3.2M
Total cash	CAD 162,703
Total debt	CAD 0
Total liabilities	CAD 1.8M
WACC	-11.61%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	CAD 336,137
Current liabilities	CAD 1.8M
Current ratio	0.18
Net working capital	CAD -1.6M
Quick ratio	0.16
Working capital	CAD -1.5M
Working capital turnover	-0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-58.05%
Shareholder yield	-58.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.06
1D price change	0%
1M price change	-0%
1M total return	-0%
1W price change	9.09%
1W total return	9.09%
1Y price change	71.43%
1Y return CAGR	71.49%
1Y total return	71.43%
20-day SMA	CAD 0.06
200-day SMA	CAD 0.05
3M price change	50%
3M total return	50%
3Y price change	-68.42%
3Y return CAGR	-31.9%
3Y total return	-68.42%
50-day SMA	CAD 0.06
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.10
52-week high date	2026-05-22
52-week low	CAD 0.03
52-week low date	2025-11-13
6M price change	-14.29%
6M total return	-14.29%
All-time high	CAD 0.37
All-time high date	2023-10-03
All-time low	CAD 0.01
All-time low date	2024-07-05
Average true range (ATR)	CAD 0.00
Average volume	154.8K
Beta (1Y)	0.4
Beta (2Y)	-0.93
Beta (5Y)	-2.88
Change from 52-week high	-40%
Change from 52-week low	140%
Change from all-time high	-83.78%
Change from all-time low	500%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 60
High price	CAD 0.06
Low price	CAD 0.06
Monthly RSI	45.84
Open price	CAD 0.06
Previous close	CAD 0.06
Price vs 150-day SMA	3.09%
Price vs 20-day SMA	6.19%
Price vs 200-day SMA	11.52%
Price vs 50-day SMA	-2.6%
Relative volume	0.01
RSI	51.2
Sharpe ratio	1.14
Sharpe ratio (3Y)	0.86
Sortino ratio	2.09
Sortino ratio (3Y)	1.67
Volume	1K
Weekly RSI	52.01
YTD price change	71.43%
YTD total return	71.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	195.5M
Shares change (QoQ)	0.12%
Shares change (YoY)	58.05%
Shares held by insiders	2.89%
Shares outstanding	201.3M

Deeper analysis on CSE/ROVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/ROVA report

Is a complete CSE/ROVA research report available?

No complete published report is available for cse/ROVA (CSE/ROVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/ROVA (CSE/ROVA)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/ROVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/ROVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/ROVA

Frequently asked questions